Citius Pharmaceuticals, Inc. announced the pricing of an underwritten offering of 7,843,138 shares of its common stock (Common Stock) (or Common Stock equivalent) and common warrants to purchase up to an aggregate of 7,843,138 shares of Common Stock (the Offering)
August 9, 2018
· 5 min read